Revolutionary study: Estrogen protects kidneys from dangerous ferroptosis!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Research from Dresden sheds light on gender-specific kidney damage in order to develop targeted therapies for kidney diseases.

Forschung aus Dresden beleuchtet geschlechtsspezifische Nierenschäden, um gezielte Therapien für Nierenerkrankungen zu entwickeln.
Research from Dresden sheds light on gender-specific kidney damage in order to develop targeted therapies for kidney diseases.

Revolutionary study: Estrogen protects kidneys from dangerous ferroptosis!

Kidney disease is increasing worldwide and the World Health Organization (WHO) predicts that it will be one of the top five causes of death by 2050. A central problem is that diseases are often only recognized in advanced and irreversible stages. Therefore, a better understanding of the underlying disease mechanisms is urgently needed. An international research team led by scientists from the Mannheim University Medical Center and the TU Dresden has now made a significant contribution to this understanding.

In a recent study published in the journal Nature, gender differences in kidney damage have been identified. The main cause of acute kidney injury is ferroptosis, a process that leads to nephron loss. Research shows that the female sex hormone estrogen, particularly estradiol, has a protective effect on the kidneys.

The role of estrogen

Estradiol increases the kidneys' resistance to ferroptosis by scavenging harmful radicals and activating genetic programs that prevent cell death. These findings not only emphasize the importance of sex hormones for essential biological processes, but also open up new perspectives for the development of individualized treatment approaches in medicine.

A gender-specific understanding of diseases could make it possible to develop more targeted therapies for kidney diseases. This project, which is being carried out under the leadership of Prof. Andreas Linkermann (University Hospital Dresden, University Medical Center Mannheim) and Prof. Stefan Bornstein (University Hospital Dresden), was financially supported by the German Research Foundation (DFG) and other funding programs.

A step towards individualized medicine

The study is considered a major scientific success. It lays the foundation for future research aimed at enabling earlier diagnosis and tailored therapies for kidney disease. This comes as part of efforts at the University Hospital of Dresden, which coincide with an increasing body of research into gender-specific medical approaches to optimize the treatment of kidney disease.

Overall, research shows that gender differences play a significant role in the progression of kidney disease. This marks an important step in the understanding and treatment of such diseases.

In summary, the study highlights the urgency of expanding the field of research in gender medicine, as a better understanding of gender differences could lead to innovative therapies that will improve the lives of many people. Further information can be found on Science Online as well as on MedLab Portal.